Submuscular implantation of Vercise Genus™ Deep Brain Stimulation Implantable Pulse Generators with feedthrough wire break(s)
Healthcare professional
Industry member
Medical devices
20 August 2024
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
A Dear Healthcare Professional Letter has been issued by Boston Scientific Asia Pacific Pte Ltd to remind healthcare professionals to follow the steps outlined in the labeling/Instructions for Use (IFU) to implant Vercise GenusTM Deep Brain Stimulation (DBS) Implantable Pulse Generators (IPGs) within a subcutaneous pocket. Device header feedthrough (FT) wire break(s) have occurred in rechargeable Vercise GenusTM DBS IPGs that were implanted submuscular in the pectoral location. The root cause investigation for the FT wire breaks has determined that the use of a submuscular implant technique in the pectoral region can lead to additional, frequent muscle tension forces on an IPG against the patient’s ribs, especially if the device is sutured to the muscle, ultimately resulting in device header FT wire break(s). These repetitive stresses are not applicable for an IPG implanted in a subcutaneous pocket. Complete or partial breaks of device header FT wire(s) will prevent successful delivery of stimulation therapy, thus requiring removal/replacement of the device. Healthcare professionals are advised to follow existing device labeling/IFU regarding implant location within a subcutaneous pocket when implanting the IPGs. For any patient with a rechargeable Vercise Genus DBS IPG implanted submuscular in the pectoral region, a patient letter is enclosed to share with the patient. It is also recommended to monitor these patients for clinical observations of high monopolar impedances, undesired sensation, sudden loss of therapy, return of pre-implant symptoms and / or Bluetooth connectivity challenges which may be potential signals associated with FT wire break(s). Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
